Allergy Therapeutics

AGY · AIM · Health Care · mcap £306m · 4.8p

Beta Briefing, track record and bull & bear case are not ready for Allergy Therapeutics yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 38 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Dec 25

Source: results 31 Mar 26 ↗

Revenue: –
Operating profit: –
Net income: –
Free cash flow: –
Net debt: £10.1m
Market cap: £301m
EV / EBIT: –
FCF yield: –
Price / book: 70.8×

Latest half-year · H2 25 vs H2 24 results 31 Mar 26 ↗

Revenue: £36.3m
Operating profit: −£11.4m
Net income: −£19.9m
Cash from operations: −£11.8m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H2 25 (six months to 31 Dec 25), published 31 Mar 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	H2 25	vs H2 24	H2 24
Revenue	36.3	+7%	34.0
Gross profit	21.5	+3%	20.9
Operating profit	(11.4)	n/m	(5.7)
Amortisation	(0.1)	−50%	(0.2)
Share-based payments	(1.0)	n/m	0.1
Finance costs	(3.9)	+19%	(3.3)
Profit before tax	(19.3)	n/m	(11.4)
Tax	(0.6)	+15%	(0.5)
Net income (owners)	(19.9)	n/m	(11.9)
EPS basic	(0.4p)	–	(0.2p)
EPS diluted	(0.4p)	–	(0.2p)

	H2 25	vs H2 24	H2 24
Cash from operations	(11.8)	n/m	(7.3)
Tax paid	0.8	n/m	(0.0)
Capex (PP&E)	(2.8)	+96%	(1.4)
Capex (intangibles)	(0.0)	n/m	(0.1)
Lease principal paid	(0.8)	0%	(0.8)
Lease interest paid	(0.1)	−3%	(0.1)
Shares issued	1.5	n/m	0.0

	FY 25
Goodwill	3.3
Other intangibles	0.9
Inventories	13.8
Trade receivables	11.0
Cash	10.1
Current assets	36.3
Total assets	71.0
Trade payables	13.9
Borrowings, current	0.5
Lease liabilities, current	1.5
Current liabilities	32.0
Borrowings, non-current	19.7
Lease liabilities, non-current	5.1
Total liabilities	66.8
Total equity	4.2

	H2 25	H1 25
Goodwill	3.3	3.3
Other intangibles	0.9	0.9
Inventories	13.8	13.9
Trade receivables	11.0	5.9
Cash	10.1	12.8
Current assets	36.3	34.7
Total assets	71.0	67.5
Trade payables	13.9	13.6
Borrowings, current	0.5	0.4
Lease liabilities, current	1.5	1.5
Current liabilities	32.0	27.2
Borrowings, non-current	19.7	53.0
Lease liabilities, non-current	5.1	5.2
Total liabilities	66.8	95.7
Total equity	4.2	(28.2)

No annual income statement figures were extracted for this company yet. See the latest results ↗

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.